| # | Drug | Count |
|---|---|---|
| 0 | VEDOLIZUMAB | 200 |
| 1 | PREDNISONE | 142 |
| 2 | INFLIXIMAB | 104 |
| 3 | MESALAMINE | 95 |
| 4 | ADALIMUMAB | 92 |
| 5 | PANTOPRAZOLE | 69 |
| 6 | AZATHIOPRINE | 68 |
| 7 | ASPIRIN | 66 |
| 8 | ASPIRIN 325 MG | 63 |
| 9 | ASPIRIN 81 MG | 63 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SALINE LAXATIVE | 1 | 0.1250 |
| 1 | HISTAMINE | 2 | 0.0138 |
| 2 | MEBROFENIN | 1 | 0.0109 |
| 3 | HUMAN ALBUMIN MICROSPHERES AND PERFLUTREN | 1 | 0.0071 |
| 4 | PLECANATIDE | 10 | 0.0048 |
| 5 | ZIV-AFLIBERCEPT | 5 | 0.0038 |
| 6 | ETRASIMOD | 6 | 0.0035 |
| 7 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 8 | MESALAMINE | 95 | 0.0034 |
| 9 | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | 1 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 221 |
| 1 | Integrin Receptor Antagonist [EPC] | 200 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 121 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 115 |
| 4 | Aminosalicylate [EPC] | 100 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 87 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 69 |
| 7 | Platinum-based Drug [EPC] | 68 |
| 8 | Purine Antimetabolite [EPC] | 68 |
| 9 | Osmotic Laxative [EPC] | 57 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 10 | 0.0048 |
| 1 | Integrin Receptor Antagonist [EPC] | 200 | 0.0023 |
| 2 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 3 | Aminosalicylate [EPC] | 100 | 0.0010 |
| 4 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 5 | Vitamin D3 Analog [EPC] | 20 | 0.0010 |
| 6 | Methylating Agent [EPC] | 1 | 0.0010 |
| 7 | Chloride Channel Activator [EPC] | 7 | 0.0007 |
| 8 | Allylamine Antifungal [EPC] | 5 | 0.0007 |
| 9 | Purine Antimetabolite [EPC] | 68 | 0.0007 |